Skip to main content
. 2019 Jun 19;11(6):288. doi: 10.3390/pharmaceutics11060288

Figure 5.

Figure 5

(a) 4,5-dimethylthiazol-2,5-diphenyltetrazolium bromide (MTT) and (b) sulforhodamine B (SRB) cell viability of f-MSNs and 5-FU-loaded MSNs administered at various concentrations (20, 50, and 100 μg/mL) in HEK293 cells. Data is represented as mean ± SD (n = 3). * p < 0.05 was considered statistically significant.